Clinical evaluation of RSA pacing in post-surgery patients

接受心脏手术的病人经常发现，在手术后的恢复期，他们的心脏很难向身体供应足够的血液。Ceryx开发了一种独特的起搏装置，能够提高心脏的性能，同时也减少了心脏的工作量，这可以帮助心脏愈合。在这个项目中，Ceryx将在心脏手术后的患者中试用其新技术。Ceryx将把他们的技术与现有的临时起搏装置相结合，患者在手术期间通常会安装这种装置。在Ceryx技术的驱动下，该设备将向心脏输送治疗性起搏，直到患者准备出院，通常在大约一周后。在此期间，将监测患者的心脏功能和结构的改善情况。患者的运动能力、症状和生活质量也将被评估。如果试验成功，该项目将大大加速Ceryx技术的发展，并可能在1-2年内将一种用于心脏手术患者康复的新疗法推向市场。

Patients who undergo cardiac surgery often find their hearts struggle to supply enough blood to the body during the recovery period post-surgery. Ceryx have developed a unique pacing device which is able to boost the performance of the heart while also reducing the workload on the heart, which can help the heart to heal. In this project, Ceryx will trial its new technology in patients following cardiac surgery.Ceryx will interface their technology to an existing temporary pacing device which patients are routinely fitted with during surgery. Driven by Ceryx's technology this device will then deliver the therapeutic pacing to the heart until the patient is ready to be discharged, usually after about a week. During this time the patient's heart will be monitored for improvements in function and structure. The patients' ability to exercise will also be assessed, along with their symptoms and quality of life.If the trial is successful, this project will have accelerated the development of Ceryx's technology considerably and it may be that a new therapy for patients recovering from cardiac surgery could be on the market in 1-2 years.